DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Armand P, Shipp MA, Ribrag V. et al.
Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure.
J Clin Oncol 2016;
34: 3733-3739
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.